| Synonyms: | |
| Status: | Approved (2017) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N04BD03 |
| UNII: | 90ENL74SIG |
| InChI Key | NEMGRZFTLSKBAP-LBPRGKRZSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C17H19FN2O2 |
| Molecular Weight | 302.35 |
| AlogP | 2.37 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 64.35 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 22.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Monoamine oxidase B inhibitor |
| Primary Target | |
|---|---|
| Monoamine oxidase B |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
15000 | 0.023-223500 | 187.2 | 2.29-450 | -1.6-30.5 | |
|
Enzyme
Transferase
|
- | - | - | - | 12.51 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | 83.64-88.79 | |
|
Ion channel
Voltage-gated ion channel
Voltage-gated sodium channel
|
- | 33000-100000 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Multiple System Atrophy | 2 | D019578 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 133865-89-1 |
| ChEBI | 134718 |
| ChEMBL | CHEMBL396778 |
| DrugBank | DB06654 |
| DrugCentral | 4921 |
| FDA SRS | 90ENL74SIG |
| Guide to Pharmacology | 8291 |
| PubChem | 131682 |
| SureChEMBL | SCHEMBL69350 |
| ZINC | ZINC000053084692 |